Handout to Thomson Reuters Foundation/Courtesy of NBIRT NewsDefend the Planet
India s Solar Man Sets Up Clean Energy Solution for People Living in Poverty
Chaudhuri’s solar energy project has transitioned to helping India cut carbon emissions.
By Moushumi Basu
KOLKATA, India, April 16 (Thomson Reuters Foundation) Since he was a child, Santipada Gon Chaudhuri had sought ways to help India s rural poor, so when the electrical engineer was invited to visit a coworker s home in the Himalayan village of Herma in the early 1980s, he saw his chance. I was appalled to see how local communities were living in darkness after sunset, remembered Chaudhuri, 71, who then worked for the government in the northeastern state of Tripura.
Vaccine Hesitancy Runs Through My Community Here s Why I Got the COVID-19 Shot Anyway
globalcitizen.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalcitizen.org Daily Mail and Mail on Sunday newspapers.
Composting 101: 3 Ways Global Citizens Can Start Composting and Protect the Planet
globalcitizen.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalcitizen.org Daily Mail and Mail on Sunday newspapers.
5 Wins to Celebrate During the World s COVID-19 Vaccine Rollout
globalcitizen.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalcitizen.org Daily Mail and Mail on Sunday newspapers.
Urgent Calls to Tackle Vaccine Hesitancy as African Union Drops AstraZeneca
Health experts say public awareness campaigns are needed to fight misinformation about the shot.
By Kim Harrisberg
JOHANNESBURG, April 9 (Thomson Reuters Foundation) Wariness about taking AstraZeneca s COVID-19 vaccine in Africa could be compounded by the African Union s decision to halt plans to procure the shot, health experts said on Friday, calling for public awareness programmes to fight misinformation.
The African Union (AU) said its announcement was not related to recent findings by European and British medicine regulators that there are possible links between the vaccine and extremely rare blood clots, but rather a case of diversifying options.